Your search returned 6 results.

Results
	1.	Effects of single doses of avagacestat (BMS-708163) on cerebrospinal fluid Aβ levels in healthy young men. [electronic resource] by Tong, Gary Castaneda, Lorna Wang, Jun-Sheng Sverdlov, Oleksandr Huang, Shu-Pang Slemmon, Randy Gu, Huidong Wong, Oi Li, Hewei Berman, Robert M Smith, Christina Albright, Charles Dockens, Randy C Producer: 20130711 In: Clinical drug investigation vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A placebo-controlled, multiple ascending dose study to evaluate the safety, pharmacokinetics and pharmacodynamics of avagacestat (BMS-708163) in healthy young and elderly subjects. [electronic resource] by Dockens, Randy Wang, Jun-Sheng Castaneda, Lorna Sverdlov, Oleksandr Huang, Shu-Pang Slemmon, Randy Gu, Huidong Wong, Oi Li, Hewei Berman, Robert M Smith, Christina Albright, Charles F Tong, Gary Producer: 20130214 In: Clinical pharmacokinetics vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat. [electronic resource] by Tong, Gary Wang, Jun-Sheng Sverdlov, Oleksandr Huang, Shu-Pang Slemmon, Randy Croop, Robert Castaneda, Lorna Gu, Huidong Wong, Oi Li, Hewei Berman, Robert M Smith, Christina Albright, Charles F Dockens, Randy Producer: 20130805 In: British journal of clinical pharmacology vol. 75 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral γ-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile, pharmacokinetic parameters, and pharmacodynamic markers. [electronic resource] by Tong, Gary Wang, Jun-Sheng Sverdlov, Oleksandr Huang, Shu-Pang Slemmon, Randy Croop, Robert Castaneda, Lorna Gu, Huidong Wong, Oi Li, Hewei Berman, Robert M Smith, Christina Albright, Charles F Dockens, Randy C Producer: 20120716 In: Clinical therapeutics vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease. [electronic resource] by Janelidze, Shorena Stomrud, Erik Smith, Ruben Palmqvist, Sebastian Mattsson, Niklas Airey, David C Proctor, Nicholas K Chai, Xiyun Shcherbinin, Sergey Sims, John R Triana-Baltzer, Gallen Theunis, Clara Slemmon, Randy Mercken, Marc Kolb, Hartmuth Dage, Jeffrey L Hansson, Oskar Producer: 20200731 In: Nature communications vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Pharmacodynamics of selective inhibition of γ-secretase by avagacestat. [electronic resource] by Albright, Charles F Dockens, Randy C Meredith, Jere E Olson, Richard E Slemmon, Randy Lentz, Kimberley A Wang, Jun-Sheng Denton, R Rex Pilcher, Gary Rhyne, Paul W Raybon, Joseph J Barten, Donna M Burton, Catherine Toyn, Jeremy H Sankaranarayanan, Sethu Polson, Craig Guss, Valerie White, Randy Simutis, Frank Sanderson, Thomas Gillman, Kevin W Starrett, John E Bronson, Joanne Sverdlov, Oleksandr Huang, Shu-Pang Castaneda, Lorna Feldman, Howard Coric, Vlad Zaczek, Robert Macor, John E Houston, John Berman, Robert M Tong, Gary Producer: 20130618 In: The Journal of pharmacology and experimental therapeutics vol. 344 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)